HIGH
CVE-2026-7766
CWE-22Published: May 25, 2026· Updated: May 26, 2026
8.3
CVSS v3.1
EPSS:0.04%probability of exploitation in 30 daysPercentile:12.2th
Official Description
Kenik Camera management Panel is vulnerable to Path Traversal vulnerability. An unauthenticated attacker can send GET request with arbitrary file path and read corresponding files located on the server.
The issue was fixed in version 2026-04-23 of the KG-5260xxxx-IL-(G)2 cameras.
Rest of the products were fixed in version 2025-04-21.
Technical Analysis
CVE-2026-7766 requires adjacent network access, limiting remote exploitation but still posing risk in shared or local network environments.
The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorAdjacent
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeX
Impact
Confidentiality
Integrity
Availability
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
All References (1)
Quick Facts
CVE IDCVE-2026-7766
CVSS Score8.3 / 10
SeverityHIGH
WeaknessCWE-22
CISA KEVNo
EPSS (30d)0.04%
PublishedMay 25, 2026
Related CVEs (CWE-22)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2026-7766 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.